CHRISTINE STEFFANO: Open Payments
NPI 1952826018 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,074 in 72 payments from 12 companies in 2025. Trend: 2023 $1,526 · 2024 $1,374 · 2025 $1,074
Food & beverage: $1,074
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 14 | $328 |
| Amgen Inc. | 19 | $208 |
| GlaxoSmithKline, LLC. | 13 | $186 |
| Janssen Biotech, Inc. | 17 | $183 |
| Medtronic, Inc. | 1 | $37 |
| UCB, Inc. | 2 | $28 |
| Almatica Pharma LLC | 1 | $23 |
| Grifols USA, LLC | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: COSENTYX, BENLYSTA, TREMFYA, KRYSTEXXA, ENBREL, TAVNEOS, STEALTHSTATION S8 PLATFORM, Bimzelx.
Industry payments across TX — which companies pay providers there.
